Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study | Zendy

Maryam Alavi | Zendy; Jason Grebely | Zendy; Michelle Micallef | Zendy; Adrian Dunlop | Zendy; Annie C. Balcomb | Zendy; Carolyn Day | Zendy; Carla Treloar | Zendy; Nicky Bath | Zendy; Paul Haber | Zendy; Gregory J. Dore | Zendy

Open Access

Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study

Author(s) -

Maryam Alavi,

Jason Grebely,

Michelle Micallef,

Adrian Dunlop,

Annie C. Balcomb,

Carolyn Day,

Carla Treloar,

Nicky Bath,

Paul Haber,

Gregory J. Dore

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit305

Subject(s) - medicine , hepatitis c , odds ratio , hepatitis c virus , population , confidence interval , demography , immunology , environmental health , virus , sociology

Access to hepatitis C virus (HCV) treatment remains extremely limited among people who inject drugs (PWID). HCV assessment and treatment was evaluated through an innovative model for the provision of HCV care among PWID with chronic HCV infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research